Bigfoot Biomedical Annual Revenue, Number of Employees, Growth and Funding
Estimated Revenue & Financials
- Bigfoot Biomedical's estimated annual revenue is currently $25.1M per year.
- Bigfoot Biomedical received $55.0M in venture funding in March 2018.
- Bigfoot Biomedical's estimated revenue per employee is $251,000
- Bigfoot Biomedical's total funding is $106.9M.
- Bigfoot Biomedical has 100 Employees.
- Bigfoot Biomedical grew their employee count by -24% last year.
- Bigfoot Biomedical currently has 1 job openings.
|Jeremy Ross||Senior Manager Of Model-based Design|
|Suman Datta||Director of Commercial|
|Max Gill||Vice President Market Access & Reimbursement|
|Andrew Bochenko||Senior Product Manager|
|Lesli Desimone||Director of Clinical Research Programs|
|Yongbo Wang||Senior Manager|
|Geoffrey Shipsides||General Counsel|
|Steve Green||Director Of Information Security|
|Nitya Narayanan||Director of Regulatory Affairs|
|Lee Bui||Director, Quality Engineering|
What Is Bigfoot Biomedical?
Bigfoot Biomedical is a new kind of medical device company developing technologies to significantly reduce the cognitive, emotional, and financial burden of insulin-requiring diabetes. With an intense focus on ease of use, Bigfoot will optimize the dosing and delivery of insulin through an integrated medical device ecosystem powered by machine learning and enhanced by secure, user-friendly consumer technologies, fundamentally changing the paradigm of care. The company's pioneering smartphone-enabled systems include both automated infusion pump and connected insulin pen options for consumers and will be delivered via a first-of-its-kind monthly subscription service model. Bigfoot will be the first company to deliver a monthly subscription-based service leveraging a smart, connected insulin dosing platform to meet the needs of a diverse population with insulin-requiring diabetes. Bigfoot's investigational system is comprised of best-in-class proprietary and licensed components holistically and securely integrated, leveraging intuitive design, machine learning, and a mobile app running on an off-the-shelf smartphone, all designed to keep glucose levels in an optimal range. The net result is a company that brings something unique to the table: a remarkable depth of knowledge and technical know-how combined with the personal motivation and direct patient experience necessary to really make a difference in this space. ---The MedTech Strategist, October 24, 2016keywords:Biotechnology,Healthcare,Medical Devices,Pharmaceuticals
Number of Employees
Employee Growth %
|Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|Centro Medico D...||$21.3M||85||9%||N/A|
Bigfoot Biomedical News
Artificial Pancreas Devices Systems Market By Major Players Medtronic, Bigfoot Biomedical, Beta Bionics, Admetsys, Insulet, Tandem Diabetes ...
Some of the key players operating in this market include: Medtronic, Bigfoot Biomedical, Beta Bionics. Development policies and plans are ...
Animas, BD, Bigfoot Biomedical, Boston Scientific, CCS Medical, Dexcom, Eli Lilly, Gluco-Chaser, GluSense, GlySens, Insulet, Medtronic.
Bigfoot Biomedical Funding
|2017-12-19||$37.0M||Undisclosed||Janus Henderson Investors||Article|
Bigfoot Biomedical Executive Hires
|2018-10-22||Ian Hanson||Chief Technology Officer||Article|